| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000002081 |
| Receipt No. | R000002537 |
| Official scientific title of the study | preoperative combined chemothrapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer; multicentric phase II study |
| Date of disclosure of the study information | 2009/07/01 |
| Last modified on | 2018/06/23 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | preoperative combined chemothrapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer; multicentric phase II study | |
| Title of the study (Brief title) | preoperative DCS therapy in local advanced gastric cancer | |
| Region |
|
|
| Condition | ||
| Condition | local advanced gastric cancer (excluding T3-4, bulky N2 & N3 and giant type3 & type 4) | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of preoperative combined chemotherapy with docetaxel, cisplatin and S-1 in local advanced gastric cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | pathological response |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | 2 courses of DCS therapy followed by gastrectomy.
docetaxel 35mg/m2/ D1, 8/ q4w cisplatin 35mg/m2/ D1, 8/ q4w S-1 80mg/m2/ D1-14/ q4w |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) histologically confirmed gastric adenocarcinoma
2) local advanced gastric cancer (T3-4, absence of peritoneal metastases confirmed by laparoscopy) 3) esophageal invasion < 3cm 4) age of 20-75 5) PS 0-1 (ECOG) 6) no prior treatment 7) no obvious bleeding from primary tumor 8) enable to ingestion 9) adequate organ function 10) written informed consent |
|||
| Key exclusion criteria | 1) obvious infection
2) severe complication 3) active other malignancies 4) distant metastases 5) motor palalysis or peripheral neuropathy 6) drug hypersensitivity 7) mental disorder 8) possibility of pregnancy 9) judged as unsuitable by the doctor in charge |
|||
| Target sample size | 55 | |||
| Research contact person | |
| Name of lead principal investigator | Atsushi Nashimoto |
| Organization | Society for the study of DCS therapy |
| Division name | Surgery, Niigata Cancer Center Hospital |
| Address | 2-15-3 Kawagishi-chou, Niigata |
| TEL | 025-266-5112 |
| nasimoto@niigata-cc.jp | |
| Public contact | |
| Name of contact person | Sachio Fushida |
| Organization | Kanazawa University Hospital |
| Division name | Gastroenterological Surgery |
| Address | 13-1 Takara-machi, Kanazawa |
| TEL | 076-265-2362 |
| Homepage URL | |
| fushida@staff.kanazawa-u.ac.jp | |
| Sponsor | |
| Institute | Society for the study of DCS therapy |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000002537 |